Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.48 |
| ▸ | PPARD | Q03181 | 1/20 | 0.48 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.48 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.44 |
| ▸ | FDPS | P14324 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.43 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | ADH1B | P00325 | 1/20 | 0.41 |
| ▸ | ADH1C | P00326 | 1/20 | 0.41 |
| ▸ | ADH1A | P07327 | 1/20 | 0.41 |
| ▸ | ADH4 | P08319 | 1/20 | 0.41 |
| ▸ | ADH7 | P40394 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28522745 | 1.00 | — | — | |
| SCHEMBL28412813 | 1.00 | MAPT (0.54) | MAPTCES2LCKPPARDZDHHC20 | |
| SCHEMBL578477 | 0.97 | — | — | |
| SCHEMBL578379 | 0.88 | — | — | |
| SCHEMBL27629247 | 0.78 | MAPT (0.48) | MAPTCES2LCKPPARDZDHHC20 | |
| SCHEMBL6393139 | 0.78 | MAPT (0.48) | MAPTCES2LCKPPARDZDHHC20 | |
| SCHEMBL9142634 | 0.78 | MAPT (0.48) | MAPTCES2LCKPPARDZDHHC20 | |
| SCHEMBL5022714 | 0.78 | MAPT (0.48) | MAPTCES2LCKPPARDZDHHC20 | |
| SCHEMBL2686495 | 0.78 | — | — | |
| SCHEMBL24926247 | 0.77 | MAPT (0.52) | MAPTCES2GPR84FDPSTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022213823-A1 | NON-AQUEOUS ELECTROLYTE FOR LITHIUM ION BATTERY AND LITHIUM ION BATTERY | 深圳新宙邦科技股份有限公司 | 2022-10-13 | — | — | WO | claimed |
| US-20230287001-A1 | Organic Semiconducting Compounds | RAYNERGY TEK INC (TW) | 2023-09-14 | — | — | US | disclosed |
| WO-2022213823-A1 | NON-AQUEOUS ELECTROLYTE FOR LITHIUM ION BATTERY AND LITHIUM ION BATTERY | 深圳新宙邦科技股份有限公司 | 2022-10-13 | — | — | WO | disclosed |
| EP-2686402-A1 | LIQUID CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2014-01-22 | — | — | EP | disclosed |
| WO-2012126562-A1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2012-09-27 | — | — | WO | disclosed |
| EP-2475742-A1 | LIQUID-CRYSTAL DISPLAY | Merck Patent GmbH (DE) | 2012-07-18 | — | — | EP | disclosed |
| WO-2011029510-A1 | LIQUID-CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2011-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230287001-A1 | Organic Semiconducting Compounds | OCIAD2, OCIAD1, OSTC | MAPT 32/4885CES2 2829/4885LCK 960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.